Milan, Italy

Chiara Gomiero

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.5

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Chiara Gomiero: Pioneering Treatments for COVID-19 and Neuroinflammation

Introduction: Chiara Gomiero, an accomplished inventor based in Milan, Italy, has made significant strides in the field of medical innovation. With two patents to her name, she has focused on developing groundbreaking treatments that address critical health issues, including COVID-19 and neuroinflammation.

Latest Patents: Gomiero's latest patents include a method for the treatment of COVID-19 infections using palmitoylethanolamide, an endogenous compound known for its low toxicity. This innovative method involves administering a mixture of ultra-micronized and micronized palmitoylethanolamide to patients affected by COVID-19, aiming to provide an effective therapeutic approach. Additionally, her second patent revolves around a composition of acylethanolamides derived from olive oil fatty acids, which can be utilized to treat neuroinflammation. The patented acylethanolamide complex is designed to deliver significant health benefits through specially formulated mixtures.

Career Highlights: Chiara Gomiero is currently associated with Epitech Group S.p.A., where she continues her work on innovative medical solutions. Her dedication to advancing healthcare through her inventions showcases her commitment to improving patient outcomes and addressing pressing medical challenges.

Collaborations: Throughout her career, Gomiero has partnered with notable colleagues, including Francesco Della Valle and Maria Federica Della Valle. These collaborations have further enriched her research and contributed to the successful development of her innovative treatments.

Conclusion: Chiara Gomiero stands out as a prominent figure in the realm of medical innovations. With her patents targeting critical health issues such as COVID-19 and neuroinflammation, she exemplifies the impactful role inventors play in enhancing healthcare. Her ongoing work at Epitech Group S.p.A. alongside her esteemed collaborators promises to foster further advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…